Related Experiment Video

Updated: May 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

[Interpretation and inform guide on the anti HCV antibody]

Jorge Hernández-Calleros

    Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
    |April 19, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
    11:28

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

    Published on: March 13, 2015

    Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
    06:28

    Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

    Published on: October 1, 2015

    Related Experiment Videos

    Last Updated: May 12, 2026

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
    11:28

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

    Published on: March 13, 2015

    Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
    06:28

    Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

    Published on: October 1, 2015

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

    Articles linked to this work by shared authors, journal, and citation graph.

    Pancreatogenic Diabetes, 2 Onset Forms and Lack of Metabolic Syndrome Components Differentiate It From Type 2 Diabetes.

    Pancreas·2022

    Utility of endoscopic ultrasound in idiopathic acute recurrent pancreatitis.

    BMJ open gastroenterology·2021

    A Nondilated Main Pancreatic Duct Predicts Type 2 Autoimmune Pancreatitis: Comparative Study of Resected Pancreatic Head Masses.

    Digestion·2019

    Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease.

    Medical hypotheses·2018

    Abnormal Cardiovascular Findings in Acute Pancreatitis: Are They Associated with Disease Severity?

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2017

    Serous Cystadenomas Follow a Benign and Asymptomatic Course and Do Not Present a Significant Size Change During Follow-Up.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2016

    Silencing of SEPT9 inhibits proliferation and migration of endometriotic stromal cells via suppression of the PI3K/AKT signaling pathway.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

    Reference equations for maximal inspiratory and expiratory pressures: From childhood to advanced age.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

    Precision therapeutics and innovative clinical trial design in neurodegenerative diseases.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

    Interrelationship between Oral Health, Nutrition, and Frailty in Older Adults: A Basis for Moderating Mediation Model.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

    Huntington's disease in the era of somatic instability, biomarkers, and targeted therapies: A narrative review.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

    Respiratory health and quality of life in chronic cannabis users: An exploratory study.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

    Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients.

    The Journal of antimicrobial chemotherapy·2026

    Monotypic IgA nephropathy: A large health system experience.

    Clinical nephrology·2026

    Association of elevated homocysteine levels with renal pathology and function in patients with IgA nephropathy: a single-center retrospective study.

    Annals of medicine·2026

    Intestinal Ultrasound in Inflammatory Bowel Disease: Monitoring Inflammation and Treatment Response.

    Journal of inflammation research·2026

    Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

    Open forum infectious diseases·2026

    Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy.

    Frontiers in medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us